Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede
← Scopes/
Novel Coronavirus SurveillanceRespiratory
  • Overview
  • Synthesis
  • Assessments
  • Evidence

Public note

For situational awareness and research transparency. Not medical advice.

Respiratoryactive

Novel Coronavirus Surveillance

Continuous monitoring of SARS-CoV-2 variant evolution, immune escape mutations, and signals of novel coronavirus emergence in animal reservoirs.

Open assessments

3

Tracked assessments currently open in this scope.

Evidence items

183

Source-attributed evidence available to this scope.

Source feeds

4

Configured sources contributing data to this investigation.

Last activity

Apr 11, 2026

Most recent scope activity captured in the system.

Evidence quality mix

T038
T162
T249
T322
T412

01

Synthesis

The current analyst view of this scope, at increasing levels of depth.

Routine surveillance. No novel emergence signals.

SARS-CoV-2 variant monitoring continues with JN.1 sublineages dominating globally. No signals of novel coronavirus emergence from animal reservoirs. Wastewater surveillance in 14 countries shows stable or declining viral loads. The system tracks immune escape mutations in spike RBD and monitors bat and pangolin coronavirus discovery papers for recombination signals.

02

Assessments

Open assessments being tracked inside this scope, ordered for fast review.

SARS-CoV-2 JN.1 sublineage wastewater signals will decline below 2025 baseline in the US by March 2026.

Outbreak Direction·resolved·90%·Through Mar 31, 2026·28 linked items·Mar 5, 2026

03

Recent evidence

The most recent source-attributed evidence flowing into this investigation.

CDC MMWR reports wastewater SARS-CoV-2 viral loads below 2025 seasonal baseline in 48 of 50 US states as of epi-week 9, 2026.

Mar 5, 2026
T1·CDC MMWR·1 linked assessment